Cambridge id 5925095

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: Cambridge id 5925095
• 英文别名: 2-[3-(benzimidazol-1-yl)-2-hydroxypropoxy]benzoic acid
• 化学式: C₁₇H₁₆N₂O₄
• 分子量: 312.32
• InChiKey: VJNQOOSCWTVZNK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  84.6
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Transcription factor modulating compounds and methods of use thereof
  申请人：Levy Stuart B.

  公开号：US20090131401A1

  公开（公告）日：2009-05-21

  Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing antibiotic resistance and inhibiting biofilms.

  本发明提供了可用作抗感染剂的取代苯并咪唑化合物，其可降低微生物的耐药性、毒力或生长。本发明还提供了制备和使用取代苯并咪唑化合物的方法，以及其制备的药物制剂，例如用于减少抗生素耐药性和抑制生物膜的制剂。
• TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF
  申请人：LEVY Stuart B.

  公开号：US20110230523A1

  公开（公告）日：2011-09-22

  Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing antibiotic resistance and inhibiting biofilms.

  本发明提供了用作抗感染剂的取代苯并咪唑化合物，可以降低微生物的抗性、毒力或生长。本发明还提供了制备和使用取代苯并咪唑化合物的方法，以及制备其药物制剂，例如，在减少抗生素抗性和抑制生物膜方面的应用。
• Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof
  申请人：Schmidt Ann Marie

  公开号：US10265320B2

  公开（公告）日：2019-04-23

  Amino, amido, and heterocyclic compounds are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diabetes complications, inflammation, and neurodegeneration, obesity, cancer, ischemia/reperfusion injury, cardiovascular disease and other diseases related to RAGE activity.

  本发明公开了氨基化合物、氨基化合物和杂环化合物。这些化合物可制备成药物组合物，并可用于预防和治疗包括人类在内的哺乳动物的多种疾病，包括非限制性的糖尿病并发症、炎症、神经变性、肥胖症、癌症、缺血/再灌注损伤、心血管疾病和其他与 RAGE 活性有关的疾病。
• Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof
  申请人：Schmidt Ann Marie

  公开号：US10729695B2

  公开（公告）日：2020-08-04

  Amino, amido, and heterocyclic compounds are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diabetes complications, inflammation, and neurodegeneration, obesity, cancer, ischemia/reperfusion injury, cardiovascular disease and other diseases related to RAGE activity.

  本发明公开了氨基化合物、氨基化合物和杂环化合物。这些化合物可制备成药物组合物，并可用于预防和治疗包括人类在内的哺乳动物的多种疾病，包括非限制性的糖尿病并发症、炎症、神经变性、肥胖症、癌症、缺血/再灌注损伤、心血管疾病和其他与 RAGE 活性有关的疾病。
• AMINO, AMIDO AND HETEROCYCLIC COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF
  申请人：Schmidt Ann Marie

  公开号：US20150094307A1

  公开（公告）日：2015-04-02

  Amino, amido, and heterocyclic compounds are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diabetes complications, inflammation, and neurodegeneration, obesity, cancer, ischemia/reperfusion injury, cardiovascular disease and other diseases related to RAGE activity.